Ambulatory Care Pharmacy

BCACP Preview Image

Ambulatory Care Pharmacy Specialty Certification (BCACP®)

Target Population: Pharmacists who provide integrated and accessible healthcare services to patients in outpatient settings with an emphasis on comprehensive disease state and medication management, patient education, and continuity of care.

Program Purpose: To validate that the pharmacist has the advanced knowledge, skills, and experience necessary to optimize healthcare outcomes and enhance continuity of care by providing evidence-based, individualized, and comprehensive care to patients in outpatient settings.

Currently, there are more than 6,670 BPS Board-Certified Ambulatory Care Pharmacists.

Ambulatory Care Pharmacy Specialty Council Members

The purpose of the BPS Specialty Councils is to develop standards and eligibility requirements for board certification, develop examinations and passing standards for certification, and review and approve professional development programs for recertification of board-certified pharmacists. Specialty council members are at the heart of the peer-reviewed and peer-developed nature of BPS Board Certification.

Clark Kebodeaux, Chair PharmD, BCACP

Clark Kebodeaux, PharmD, BCACP, is a Clinical Associate Professor of Pharmacy Practice and Science at the University of Kentucky College of Pharmacy. Dr. Kebodeaux currently practices in an interprofessional ambulatory clinic at the Bluegrass Community Health Center—a Federally Qualified Health Center (FQHC) that is an accredited Patient Centered Medical Home (PCMH) with a focus on diabetes, substance use disorders and underserved populations. Dr. Kebodeaux currently serves as the Residency Program Director for the PGY1 University of Kentucky Community-Based Residency Program and preceptor for PGY2 Ambulatory Care Residency at Bluegrass Community Health Center/University of Kentucky College of Pharmacy.

Jessica W. Merrey, Vice Chair PharmD, MBA, BCPS, BCACP, BCGP

Jessica Merrey is the Lead Clinical Pharmacy Specialist in Ambulatory Care at The Johns Hopkins Hospital where she has worked since 2008. She provides chronic disease management to patients in a variety of settings including Internal Medicine, Anticoagulation, and Geriatric primary care. She graduated with her PharmD from The Medical University of South Carolina in 2007, and completed a PGY-1 with Emphasis in Ambulatory Care at The Ralph Johnson VA Medical Center in Charleston South Carolina in 2008. In addition to Ambulatory Care, she is board-certified in Pharmacotherapy and Geriatric Pharmacy.

Kevin N. Astle, PharmD, CPh, BCPS, BCACP, AAHIVP, CDCES

Kevin N. Astle, PharmD, BCPS, BCACP, AAHIVP, CDCES is an Associate Professor with the University of South Florida Taneja College of Pharmacy (USF TCOP) in the Department of Pharmacotherapeutics and Clinical Research. Through USF TCOP Dr. Astle practices with the Tampa General Medical Group, Metro Inclusive Health, and USF Heath Pediatric Infectious Diseases. He joined USF in July 2022 from his previous institution, Auburn University Harrison College of Pharmacy in Mobile AL. Dr. Astle graduated from pharmacy school at the University of Florida in 2016 and completed a PGY-1 ambulatory care pharmacy residency with Auburn University Clinical Health Services in 2017.

Dr. Astle’s clinical practice and research interests are in the treatment and prevention of HIV, addressing health disparities in the LGBTQIA+ community, and prevention of cardiovascular disease in people living with HIV. Dr. Astle is passionate about advocacy and policy change regarding healthcare access for sexual and gender minorities and expanding access to healthcare for transgender patients. He is a Board-Certified Pharmacotherapy Specialist, Ambulatory Care Pharmacist, HIV Pharmacist, and Certified Diabetes Care and Education Specialist.

Joshua Bayer
Joshua Bayer, PharmD, BCPS

Bayer is an Outpatient Pharmacist at Gundersen Health System (becoming Emplify Health) where he works in an ACHC-accredited Specialty Pharmacy in La Crosse, WI. He previously provided chronic disease management in Primary Care at the Department of Veterans’ Affairs. Additional experience includes a role with the University of Colorado Hospital Infectious Disease Clinic providing care to patients living with HIV, hepatitis C, STIs, and other infections as well as a Medical Home Pharmacist with Vivent Health in Denver, CO providing chronic disease management and HIV treatment and prevention services. He received his PharmD from the University of Michigan before completing a PGY1 residency at the Milwaukee VAMC.

Erin “Tate” Drees, PharmD, BCACP

Tate Drees, PharmD, BCACP, is a Clinical Pharmacy Practitioner at Novant Health in Charlotte, North Carolina. Dr. Drees currently practices in an interprofessional ambulatory clinic at the Heart and Vascular Institute with a primary focus on heart failure, lipid management, atrial fibrillation, and hypertension. Dr. Drees received her Doctor of Pharmacy from the University of Kentucky and went on to complete her PGY1 at the Rocky Mountain Regional VA Center followed by her PGY2 at Kaiser Permanente in Colorado in Ambulatory Care.

Hillary Duvivier, PharmD, BCPS, BCACP, NCPS-D

Commander Hillary Duvivier is a U.S. Public Health Service Officer and is assigned to the Immigration and Customs Enforcement Health Service Corps (IHSC) in Miami, Florida. As a primary care provider with broad diagnostic and prescriptive authority she focuses on the management of chronic diseases however provides care to mental health and acute care patients as well. CDR Duvivier oversees an opt-out STD program and manages transitions of care for all emergent and specialty care for an 800-bed facility. She completed a PGY1 Pharmacy Practice Residency with the Indian Health Service (IHS) and later lead the establishment of the second IHS PGY2 Ambulatory Care Residency in Whiteriver, AZ.

Stacy Gee, PharmD, BCACP

Gee is an adjunct assistant professor for experiential teaching through the University of Oklahoma Health Sciences Center. She currently practices at The Chickasaw Nation Employee Health Clinic in Ada, Oklahoma, an interprofessional ambulatory clinic. She received her Doctor of Pharmacy from the University of Oklahoma Health Sciences Center.  With over 20 year of clinical pharmacy practice, she has served in various positions including: Clinical Coordinator, Residency Program Director, Pharmacy and Therapeutics (P&T) coordinator, diabetes care center pharmacist. She has practiced under collaborative practice, protocol based and standing order agreements. Her professional and research interests include women’s health, diabetes, compounding, anticoagulation, hyperlipidemia and pharmacogenomics. She is currently training in functional medicine.

Katherine Montag Schafer, PharmD, BCACP, CDCES

Montag Schafer is an Associate Professor in the Department of Family Medicine and Community Health at the University of Minnesota. She is a faculty member with the St. John’s Family Medicine Residency Program and practices at M Health Fairview Phalen Village Family Medicine Clinic. As an Adjunct Assistant Professor with the University of Minnesota College of Pharmacy, she is a preceptor for students on their APPE patient care elective rotation. She is a graduate from North Dakota State University College of Pharmacy and completed PGY1 Pharmacy Practice and PGY2 Ambulatory Care training at Hennepin County Medical Center.

Jennifer Rosselli, PharmD, BCACP, BC-ADM, CDCES

Rosselli is a Clinical Associate Professor at the Southern Illinois University Edwardsville School of Pharmacy. She received her Doctor of Pharmacy degree from St. Louis College of Pharmacy and completed a Pharmacy Practice residency at St. Elizabeth’s Hospital in Belleville, IL. She collaborates with primary care providers in a Federally Qualified Health Center to provide outpatient diabetes management and cardiometabolic risk reduction services at two SIHF Healthcare clinics. Her service, teaching, and research interests include diabetes care and support in adults, expanding the role of pharmacists in primary care, and enhancing well-being among pharmacy learners, pharmacists, and pharmacy personnel.

Christie Schumacher, PharmD, BCPS, BCACP, BCCP, BC-ADM, CDCES, FCCP

Schumacher is a Professor in the Department of Pharmacy Practice at Midwestern University College of Pharmacy, Downers Grove Campus, and serves as the PGY2 Ambulatory Care Pharmacy Residency Program Director. She practices as a clinical pharmacist at Northwestern Medicine in Chicago, IL, providing chronic disease management for a variety of internal medicine disease states. She received her B.S. in Biochemistry and PharmD from the University of Michigan and completed a PGY1 Pharmacy Practice Residency at Midwestern University.

Brandon Sucher, PharmD, BCACP, CDCES, AE-C

Brandon Sucher serves as the National Director of Clinical Outcomes for Revelation Pharma, a national network of 503A and 503B compounding pharmacies providing innovative and quality pharmacy preparations and services through “industry best” patient care. He also serves as the Residency Program Director for the Revelation Pharma – Innovation Compounding PGY1 Community-Based Residency Program. With over 20 years of experience in pharmacy education and practice, Sucher has served as an ambulatory care pharmacist in a variety of settings, including Veterans Affairs (VA) primary care, VA anticoagulation services, and a patient-centered medical home interprofessional teaching clinic. Throughout his career, he has been committed to optimizing patient care in areas such as anticoagulation management, asthma, COPD, diabetes, dyslipidemia, and hypertension. He earned his Doctor of Pharmacy from Texas Tech University Health Sciences Center Jerry H. Hodge School of Pharmacy and subsequently completed a Primary Care Specialty Residency with the University of Mississippi Medical Center. His professional interests include leader-development, real-world evidence studies, and patient-reported outcomes research designed to generate robust health outcomes evidence to support the use of compounded preparations in clinical practice.

Jarred Prudencio, PharmD, BCACP, BC-ADM, FCCP

Jarred Prudencio is an Associate Professor of Pharmacy Practice and the Director of Experiential Education at the University of Hawaii at Hilo. He maintains a practice site at East Hawaii Health Clinics, a network of rural health clinics including family medicine and cardiology, where he provides comprehensive medication management through a collaborative practice agreement. He precepts pharmacy students on IPPE and APPE rotations, as well as family medicine physician residents on pharmacotherapy rotations. In the didactic setting, he teaches pharmacotherapy for chronic diseases including weight management, heart failure, thromboembolic disorders, HIV, viral hepatitis, COPD, asthma, and gout. His research interests include demonstrating optimization of patient outcomes in various ambulatory care pharmacy service models and innovations in pharmacy education.

Eligibility Requirements

An applicant for board certification in Ambulatory Care Pharmacy must demonstrate all of the eligibility requirements listed below. All practice and education eligibility requirements must be met before submitting the application. Once all of the requirements below are met, an applicant will be deemed eligible to sit for the Ambulatory Care Pharmacy specialty certification examination. If an applicant achieves a passing score on the Ambulatory Care Pharmacy specialty certification examination, they may use the designation Board-Certified Ambulatory Care Pharmacist, or BCACP.

  • Refer to the Ambulatory Care Pharmacy Examination Content Outline here for details on eligibility requirements, effective dates, and more.

The rationale for the appropriateness of the requirements for BPS certification programs are based upon the following:

  • BPS recognizes individuals who graduate from a recognized school or college of pharmacy within the candidate’s jurisdiction. Those jurisdictions recognize and evaluate programs on the extent to which it accomplishes its stated goals and is consistent with the concept that pharmacy is a unique, personal service profession in the health science field. In the United States, the responsibility for recognizing schools and colleges of pharmacy falls to the Accreditation Council for Pharmacy Education (ACPE).
  • The rationale for requiring licensure or registration of pharmacists within their jurisdiction is based upon the fact that for public protection, all pharmacists must be licensed or registered. This is considered a baseline requirement to be a pharmacist specialist. In the United States, BPS recognizes the licensure process administered by the National Association of Boards of Pharmacy (NABP). The National Association of Boards of Pharmacy (NABP) aims to ensure the public’s health and safety through its pharmacist license transfer and pharmacist competence assessment programs. NABP’s member boards of pharmacy are grouped into eight districts that include all 50 United States, the District of Columbia, Guam, Puerto Rico, the Virgin Islands, Bahamas, and all 10 Canadian provinces.
  • The experiential component is required to help assure practical application of components of the specialty knowledge being certified. There are multiple pathways to meet the practice experience requirement. The faster eligibility pathways recognize accredited residencies through the American Society of Health System Pharmacists (ASHP). The ASHP residency accreditation program identifies and grants public recognition to practice sites having pharmacy residency training programs that have been evaluated and found to meet the qualifications of one of the ASHP’s residency accreditations standards. Thus, accreditation of a pharmacy residency program provides a means of assurance to residency applicants that a program meets certain basic requirements and is, therefore, an acceptable site for postgraduate training in pharmacy practice in organized health care.
  • Passing the BPS pharmacy specialty examination helps assure knowledge consistent with the validated content outline for the BPS specialty.

The appropriateness of the BPS program requirements are consistent with the Council on Credentialing in Pharmacy’s Resource Paper titled: Scope of Contemporary Pharmacy Practice: Roles, Responsibilities, and Functions of Pharmacists and Pharmacy Technicians.

Upcoming Deadlines

Individuals who meet the eligibility requirements for the BCACP examination can find more information about examination dates and fees for certification examinations here

Candidate's Guide

The Candidate’s Guide is intended for use by pharmacists who are interested in becoming certified as specialists by BPS in any of the BPS-recognized specialty practice areas. To review critical information for BPS Certification Examinations, visit this page.

Content Outline for BCACP®

Refer to the Ambulatory Care Pharmacy Examination Content Outline here for details on eligibility requirements, effective dates, and more.

The examination content outline is a product of a job analysis, also known as a role delineation study, that includes discussions with a panel of 15-20 subject matter experts who represent the specialty area. These experts determine the competencies required for safe and effective pharmacy practice in the specialty area and engage board-certified pharmacists through a validation survey for their endorsement of the identified competencies. The job analysis process is conducted every 5 years to help ensure that the competencies in the examination content outline reflect current pharmacy practice in the specialty area.

  • Click here to review the 2024 BCACP® Job Analysis Summary.

Important Resources

Preparing for the BCACP® Examination

Certification is a significant differentiator, and the rigorous exam process requires concentrated study. Successful candidates are well prepared, and a number of available resources can assist pre-qualified applicants.

Suggested preparation for the examination might include:

  • The study of journal articles, textbooks or other publications related to the Content Outline.
  • Attendance at continuing education programs and courses in specialized pharmacy practice.
  • Participation in study groups and examination preparation courses.
  • Reviewing the sample examination items provided in order for candidates to familiarize themselves with the various item formats which are presented on the exam. Sample question performance should not be interpreted as an indicator of exam performance.

To maintain its strict, independent standards for certification, BPS does NOT provide review information, preparatory courses, or study guides. However, such materials are available from outside organizations, state or local professional associations and colleges of pharmacy. Potential applicants may contact the professional associations noted below for additional study resources.

The Board of Pharmacy Specialties provides the following program listing for informational purposes. This list is not an exhaustive list of options available for examination preparation. BPS does not endorse or provide preparatory courses for Board Certification Examinations.

Ambulatory Care Pharmacy

BPS partners with Pearson to provide the examination. BPS does not have any other partnerships for the certification or recertification application process. BPS partners with professional development program (PDP) providers to provide continuing pharmacy education (CPE) for recertification and the relationship is noted here. Any organization claiming a relationship with BPS for the application process or providing CPE labeled ‘BPS-approved’ outside of the organizations listed should be reported to BPS immediately.

Certification for Applicants Outside the U.S.

BPS would like to offer some helpful tips to candidates outside of the United States in order to make their application experience easier. To learn more about applying for board certification as a pharmacist outside of the U.S., visit this page.

Apply for ADA Accommodations

BPS complies with the relevant provisions of the Americans with Disabilities Act (ADA). For applicants looking to request special accommodations in their application process, more instructions can be found on this page.

Frequently Asked Questions

After review of the BPS Candidates Guide and specialty certification page, some applicants may still have questions. Visit this page to see frequently asked questions from pharmacists pursuing board certification like you!

Sample Examination Items

Sample Items for BCACP® Examinations

The sample examination items for BCACP examinations are made available by BPS for the purposes of familiarizing certification candidates and other stakeholders with the structure and format of BPS Certification Examinations. This is not meant for use as a self-assessment. Performance on any of these items does not correlate with performance on the actual examination.

The content of these examples is meant to be illustrative of actual examination items, but these items do not appear on the certification examination and are not meant to identify the scope of the examination. For a more comprehensive indication of the scope of the certification examination, please refer to the BCACP® Exam Content Outline.

Examination items are in multiple-choice format. The great majority of examination items are multiple-choice with a single response from among four options. Some examinations may include a small percentage of items that require selection of multiple (three or four) responses from among a larger set of available (up to eight) options. Examinations items may also be supplemented by an image.

View the examination items down below.

Which physical assessment finding would be consistent with an exacerbation of heart failure?

Rales
Systolic murmur
Lobar consolidation
S2 gallop

Correct!

Incorrect!

A 40-year-old patient presents to the primary care clinic and is diagnosed with group A streptococcal pharyngitis. The patient reports no other recent illnesses and no known drug allergies. Which agent is the most appropriate for antimicrobial therapy?

Penicillin
Azithromycin
Cephalexin
Levofloxacin

Correct!

Incorrect!

A woman with a history of poison-ivy allergic contact dermatitis presents with well-demarcated patches of erythema on her body as well as vesicles that are oozing and weeping on her face and hands. Which drug is most appropriate for this patient?

Topical diphenhydramine
Oral prednisone
Oral diphenhydramine
Topical triamcinolone

Correct!

Incorrect!

A pharmacy manager at a rural community outpatient clinic is thinking about starting a diabetes disease management service. What is the first step the pharmacist should take to justify this new service?

Collect patient data to assess the need for the service.
Develop a mission statement to provide a focus for the service.
Perform a SWOT analysis to determine if the service is justified.
Perform a thorough financial analysis to determine start-up costs.

Correct!

Incorrect!

In designing a clinical trial, how can inherent differences between groups at baseline be minimized?

Use of a control or comparison group
Blinding of patients and investigators
Regression models with the statistical analysis
Random assignment of patients to study groups

Correct!

Incorrect!

When making an evidence-based decision, which source would provide the highest level of evidence?

Patients with chronic migraines randomly assigned to placebo or feverfew to assess effectiveness are followed for 3 months.
A cohort of patients are followed for 5 years to examine the persistence of blood pressure lowering with lisinopril.
Meta-analysis of studies of the relationship between aspirin and bleeding events in patients with acute ischemic syndromes is performed.
An analysis of extracted data from a national medical and pharmacy claims database is used to evaluate the interaction between omeprazole and clopidogrel.

Correct!

Incorrect!

In order to assess the effect of a potential metabolic enzyme inhibitor on the clearance of warfarin, which study design would be most appropriate?

Randomized crossover study with a washout period between phases
Single-blind (investigator only), two-group parallel, controlled study
Double-blind, two-group parallel, controlled study
Single-phase study with comparison of warfarin clearance to a population average in the literature

Correct!

Incorrect!

Which study would meet "no more than minimal risk" criteria and therefore allow an institutional review board (IRB) to complete an expedited review?

Evaluation of an approved drug for an additional unapproved indication
The expected risk for severe adverse events is minimal
The expected risk is limited to mild adverse events only
Additional testing performed on previously collected patient blood samples

Correct!

Incorrect!

According to recommendations from the Centers for Medicare & Medicaid Services (CMS), what is the minimum number of allotted Comprehensive Medication Reviews (CMR) and targeted medication reviews for medication therapy management (MTM) for which Medicare patients are eligible?

Quarterly CMR with targeted medication reviews monthly
CMR twice annually with annual targeted medication reviews
CMR every 5 years with annual targeted medication reviews
Annual CMR with quarterly targeted medication reviews

Correct!

Incorrect!

When developing a new Exposure Control Plan, which action should the pharmacist recommend for exposure to patients known to have hepatitis C?

Test for antigen to the hepatitis C virus.
Treat with interferon-alfa.
Administer hepatitis C vaccine.
Test for antibody to the hepatitis C virus.

Correct!

Incorrect!

Share the quiz to show your results !

Subscribe to see your results

Ambulatory Care Pharmacy Sample Questions

I got %%score%% of %%total%% right

%%description%%

%%description%%

Loading...

Recertification Requirements for BCACP®

Pharmacists who earn the designation Board-Certified Ambulatory Care Pharmacist® (BCACP) are required to maintain their certification over a seven-year period by completing one of the following recertification pathways:

Option One: Recertification Examination

  • For BCACP with certification beginning January 1, 2023 or earlier: Achieve a passing score on the recertification examination administered by BPS.
  • For BCACP with certification beginning January 1, 2024 or later:Achieve a passing score on the recertification examination administered by BPS and self-report up to 20 units of continuing professional development (CPD).  Assessed continuing pharmacy education (CPE) from BPS-approved professional development programs can also satisfy this requirement. For more information on CPD, review the FAQ. To maintain an active certification in good standing, a minimum of two units of assessed CPE from BPS-approved professional development programs or self-reported CPD must be reported each year.

OR

Option Two: Professional Development Program

Click here to view a simplified comparison infographic to learn more about the differences between the CPE and CPD recertification frameworks.

Year certified/recertified

New cycle start

(begin earning recert units)

Cycle expiration

(deadline to meet recert reqs)

Units required 

(PDP = professional development program)

20191/1/202012/31/2026100 units assessed CPE via BPS-approved PDP
20201/1/202112/31/2027100 units assessed CPE via BPS-approved PDP
20211/1/202212/31/2028100 units assessed CPE via BPS-approved PDP
20221/1/202312/31/2029100 units assessed CPE via BPS-approved PDP
20231/1/202412/31/2030100 units (80 units assessed CPE via BPS-approved PDP + 20 units CPD)
2024 onward1/1/2025 onward12/31/2031 onward100 units (80 units assessed CPE via BPS-approved PDP + 20 units CPD)

For full details regarding recertification, please refer to the BPS Recertification Guide.

Board-Certified Ambulatory Care Pharmacists® are required to pay the BPS Annual Certification Maintenance fee of $125 each year during years one through six and the $400 recertification fee in year seven. Individuals with more than one BPS Certification are assessed one BPS Annual Certification Maintenance fee each year. 

Upcoming Deadlines

Candidates are required to recertify every 7 years. Certificants must submit their recertification application no later than the deadline of August 17. BPS encourages candidates to submit their recertification application as early as January 1 of their recertification year.

Candidates who intend to recertify via examination should note the availability of the recertification examination and related application deadlines. Candidates recertifying their BCACP® credential by examination can find more information about examination dates and fees here

Candidates who intend to recertify via continuing pharmacy education (CPE) MUST submit their recertification application by the deadline date of August 17 even if they have not completed their CPE requirements.

The deadline to complete the required CPE for recertification is December 31 for all specialties. The board-certified pharmacist is responsible for submitting an application that is completely and accurately filled out. Incomplete and/or unpaid applications will not be processed.

Recertification Guide

The recertification guide is intended to provide BPS-certified pharmacists with information on the recertification process. To review recertification information, visit this page.

CPE Providers

BCACP® with certification beginning January 1, 2023 or earlier: recertification via professional development program requires 100 units of assessed CPE from BPS-approved professional development programs offered by: 

BCACP® may participate in recertification from any BPS-approved BCACP® programs.

 

BCACP® with certification beginning January 1, 2024 or later: recertification via professional development program requires 100 units. Earn at least 80 units of of assessed continuing pharmacy education (CPE) from a BPS-approved professional development programs and self-report up to 20 units of continuing professional development (CPD) by the end of the 7 year recertification cycle (assessed CPE can also satisfy this requirement).*

* A minimum of 2 units of CPD or BPS-approved, assessed CPE must be earned annually, regardless of recertification pathway.

BCACP® may participate in recertification from any BPS-approved BCACP® programs. 

Content Outline for BCACP

Refer to the Ambulatory Care Pharmacy Examination Content Outline here for details on eligibility requirements, effective dates, and more.

The examination content outline is a product of a job analysis, also known as a role delineation study, that includes discussions with a panel of 15-20 subject matter experts who represent the specialty area. These experts determine the competencies required for safe and effective pharmacy practice in the specialty area and engage board-certified pharmacists through a validation survey for their endorsement of the identified competencies. The job analysis process is conducted every 5 years to help ensure that the competencies in the examination content outline reflect current pharmacy practice in the specialty area.

  • Click here to review the 2024 BCACP® Job Analysis Summary.

Important Resources

Logging CPD Activities (Video)

Watch a step-by-step video walkthrough of how to report CPD activities in MyBPS once a certificant begins a new certification cycle. For CPD categories and descriptions, see the “How will CPD activities contribute to recertification?” question in the CPD FAQs.

CPD Annual Reflection and Plan (ARP) Sample

Click here to view a sample Annual Reflection and Plan (ARP) to help guide formatting and structure for your CPD annual reflection and learning plan. 

CPD Activity Evaluation Sample

Click here to view a sample CPD activity evaluation (scholarly activity) to help guide how evaluations may be documented for CPD credit. This sample is for guidance and is not the only acceptable format.

Frequently Asked Questions

After review of the BPS Recertification Guide, some applicants may still have questions. Visit this page to see frequently asked questions from pharmacists renewing their board certification like you!

Sample Examination Items

Sample Items for BCACP® Examinations

The sample examination items for BCACP® examinations are made available by BPS for the purposes of familiarizing certification candidates and other stakeholders with the structure and format of BPS certification examinations. This is not meant for use as a self-assessment. Performance on any of these items does not correlate with performance on the actual examination.

The content of these examples is meant to be illustrative of actual examination items, but these items do not appear on the certification examination and are not meant to identify the scope of the examination. For a more comprehensive indication of the scope of the recertification examination, please refer to the BCACP® Exam Content Outline.

Examination items are in multiple-choice format. The great majority of examination items are multiple-choice with a single response from among four options. Some examinations may include a small percentage of items that require selection of multiple (three or four) responses from among a larger set of available (up to eight) options. Examinations items may also be supplemented by an image.

View the examination items down below.

Which physical assessment finding would be consistent with an exacerbation of heart failure?

Rales
Systolic murmur
Lobar consolidation
S2 gallop

Correct!

Incorrect!

A 40-year-old patient presents to the primary care clinic and is diagnosed with group A streptococcal pharyngitis. The patient reports no other recent illnesses and no known drug allergies. Which agent is the most appropriate for antimicrobial therapy?

Penicillin
Azithromycin
Cephalexin
Levofloxacin

Correct!

Incorrect!

A woman with a history of poison-ivy allergic contact dermatitis presents with well-demarcated patches of erythema on her body as well as vesicles that are oozing and weeping on her face and hands. Which drug is most appropriate for this patient?

Topical diphenhydramine
Oral prednisone
Oral diphenhydramine
Topical triamcinolone

Correct!

Incorrect!

A pharmacy manager at a rural community outpatient clinic is thinking about starting a diabetes disease management service. What is the first step the pharmacist should take to justify this new service?

Collect patient data to assess the need for the service.
Develop a mission statement to provide a focus for the service.
Perform a SWOT analysis to determine if the service is justified.
Perform a thorough financial analysis to determine start-up costs.

Correct!

Incorrect!

In designing a clinical trial, how can inherent differences between groups at baseline be minimized?

Use of a control or comparison group
Blinding of patients and investigators
Regression models with the statistical analysis
Random assignment of patients to study groups

Correct!

Incorrect!

When making an evidence-based decision, which source would provide the highest level of evidence?

Patients with chronic migraines randomly assigned to placebo or feverfew to assess effectiveness are followed for 3 months.
A cohort of patients are followed for 5 years to examine the persistence of blood pressure lowering with lisinopril.
Meta-analysis of studies of the relationship between aspirin and bleeding events in patients with acute ischemic syndromes is performed.
An analysis of extracted data from a national medical and pharmacy claims database is used to evaluate the interaction between omeprazole and clopidogrel.

Correct!

Incorrect!

In order to assess the effect of a potential metabolic enzyme inhibitor on the clearance of warfarin, which study design would be most appropriate?

Randomized crossover study with a washout period between phases
Single-blind (investigator only), two-group parallel, controlled study
Double-blind, two-group parallel, controlled study
Single-phase study with comparison of warfarin clearance to a population average in the literature

Correct!

Incorrect!

Which study would meet "no more than minimal risk" criteria and therefore allow an institutional review board (IRB) to complete an expedited review?

Evaluation of an approved drug for an additional unapproved indication
The expected risk for severe adverse events is minimal
The expected risk is limited to mild adverse events only
Additional testing performed on previously collected patient blood samples

Correct!

Incorrect!

According to recommendations from the Centers for Medicare & Medicaid Services (CMS), what is the minimum number of allotted Comprehensive Medication Reviews (CMR) and targeted medication reviews for medication therapy management (MTM) for which Medicare patients are eligible?

Quarterly CMR with targeted medication reviews monthly
CMR twice annually with annual targeted medication reviews
CMR every 5 years with annual targeted medication reviews
Annual CMR with quarterly targeted medication reviews

Correct!

Incorrect!

When developing a new Exposure Control Plan, which action should the pharmacist recommend for exposure to patients known to have hepatitis C?

Test for antigen to the hepatitis C virus.
Treat with interferon-alfa.
Administer hepatitis C vaccine.
Test for antibody to the hepatitis C virus.

Correct!

Incorrect!

Share the quiz to show your results !

Subscribe to see your results

Ambulatory Care Pharmacy Sample Questions

I got %%score%% of %%total%% right

%%description%%

%%description%%

Loading...

Testimonials

Holding board certifications through the Board of Pharmacy Specialties has not only provided me with a network of peers with similar clinical interests and expertise, but it allows me to demonstrate to colleagues and patients that I am clinically competent and will be able to provide the best care possible!

My certifications have opened doors to new roles and patient care, leadership, and educational opportunities. The certification process has helped me stay updated with treatment recommendations and become a stronger clinician and educator. As my career has evolved, my board certification has helped me grow. 

Dedication to quality and a desire to have a meaningful impact in the profession of pharmacy was the source of the passion and discipline needed to study for BCACP certification and maintenance. It’s not just about a few extra letters after my name. It’s about recognizing that competency is a fleeting state, and I need a steadfast commitment to lifelong learning to provide quality patient care.

As a spouse of an active-duty Air Force service member, I’m constantly moving every couple of years. BPS board certification has allowed me to stay competitive in the job market. I’ve been able to continue to work as an ambulatory care pharmacist in several states. Having BPS board certification has been highly valued by my employers as it shows proof of my pharmacy knowledge and experience.

I maintain my BPS certification as a method of high level accountability for myself, my patients, and the future pharmacists I precept and mentor. Being a board certified pharmacist often prompts conversations with pharmacy students, as they look forward to “where they see themselves in 5 years”. I welcome and enjoy those conversations, and the privilege to share what my BCACP has done for me both personally and professionally.

0/0

Certification Verification

BPS offers the ability to search and verify a Board-Certified Pharmacist by name or credential number. 

BPS Logo
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Click here to review the BPS Privacy Statement.